[Chronic effect of an acetylcholinesterase inhibitor on clinical disorders and posthistaminic gastric secretion in hypochlorhydria patients].
D000126:Achlorhydria / Q000188:drug therapy*; D000471:Alkalosis / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors; D004357:Drug Synergism; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000378:metabolism; D006636:Histamine Release; D006801:Humans; D006851:Hydrochloric Acid / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010830:Physostigmine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D002800:Cholinesterase Inhibitors; D010830:Physostigmine; D006851:Hydrochloric Acid
Action chronique d'un inhibiteur de l'acétylcholinestérase sur les troubles cliniques et sur la sécrétion gastrique posthistaminique de patients hypochlorhydriques.